Alessandro de Luca

Alessandro is the Chief Information Officer for Healthcare and he is responsible for the End2End supply chain for Merck Biopharma, the group’s pharmaceutical division. His accountability involves supply planning, artwork mgt, warehousing and distribution as well as country demand/order management. His mission encompasses the need for efficiently delivering lifesaving products to patients across the globe and for ensuring the right supply chain solutions that enhance access to health in the developing countries. In 2016, he has been elected “The Inspirational Leader of the Year” within the Merck BioPharma division. In 2015, he has been awarded the Nr 1 Pharma “Most Influential Supply Chain Executive in Europe” (among the top 5 across all industries) by the SCM magazine. Previously to his Pharma supply chain experience, he worked in Procter & Gamble (FMCG’s industry) for 20 years holding positions across Innovation&Marketing, Manufacturing, Engineering and Supply Chain Management.. He has operated in countries such as China, Russia, Venezuela, Spain and several Eastern European countries and has been based in Italy, Belgium, Switzerland and Spain.


Merck is a global science and technology company with a passion for forward-thinking discoveries. We want to develop products and solutions for a better life. That's why we take a closer look at things, ask questions and think ahead. We've been around for almost 350 years, yet the great majority of our shares are still held by the descendants of Friedrich Jacob Merck, the man who founded our company in Darmstadt in 1668. 50,000 employees in 66 countries work together with us on innovative solutions and the newest technologies in healthcare, life science and performance materials. From improving electronic devices with smarter materials to generating ultra pure water, testing the quality of food and drugs, and treating cancer, Merck always promotes opportunities to break new ground. We are Merck. The only exceptions to this are in the USA and Canada. Here we operate in the biopharma market as EMD Serono, in life science as MilliporeSigma, and in the specialty chemicals and high-tech materials business area as EMD Performance Materials.